HOME >> MEDICINE >> NEWS
New clinical research study evaluates novel cell therapy

CHICAGO- Physicians at Rush University Medical Center are testing whether a novel cell therapy using retinal pigment epithelial (RPE) cells attached to tiny gelatin bead microcarriers implanted in the brain can improve the symptoms of Parkinson's disease.

The investigational cellular product (Spheramine), which is being evaluated in a new clinical study called STEPS1, consists of RPE cells attached to microcarriers. RPE cells produce levodopa, the precursor of dopamine. Dopamine is a neurotransmitter produced by nerve cells in the brain that progressively declines as the disease progresses. The RPE cells, which are normally found in the back of the eye, are cultured under standardized conditions and attached to the microscopic beads prior to implantation. The microcarriers are necessary for the cells to survive in the brain. The implanted cells serve as a new potential source of levodopa to enhance dopamine production where it is most needed.

An earlier pilot clinical study at Emory University implanted six advanced Parkinson's patients with cells on one side of the brain. These six patients experienced sustained improvements in motor function, averaging 41 percent at 24 months following treatment. In addition, there have been no safety concerns more than two years post treatment, according to neurosurgeon Dr. Roy A.E. Bakay, now at Rush and member of the Chicago Institute of Neurosurgery and Neuroresearch (CINN) medical group, who performed the surgical implantation for the study.

Along with Bakay, Rush neurologist Dr. Leonard Verhagen is the principal investigator for the Chicago site for this new Phase IIb, blinded STEPS study. Recruitment for the 68 patients for the study has recently begun. Each patient will be followed for approximately two years.

While the pilot study evaluated treatment on just one side of the brain, the STEPS research study will implant cells bilaterally, as Parkinson's affects both sides of the brain. Half of
'"/>

Contact: Mary Ann Schultz
Mary_Ann_Schultz@rush.edu
312-942-7816
Rush University Medical Center
16-Sep-2003


Page: 1 2 3

Related medicine news :

1. British hospitals need clinical ethicists
2. Lack of clinical trial participation may contribute to lower survival rates
3. Obtaining patient consent for clinical audit is unworkable without extra resources
4. Sharing clinical trial results with participants may be beneficial
5. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
6. PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms
7. Most episodes of HIV blips not clinically significant in patients receiving HAART
8. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
9. New non-hormonal hot flash treatment set for clinical trial
10. Study naming hospitals in top 5% for clinical quality released by HealthGrades
11. Future of clinical medicine research is at risk, warns professor

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... ... Pennsylvania, is pleased to offer in-home and online newborn sleep consultations . ... has on the body,” says company owner Courtney Zentz, a pediatric sleep professional, ...
(Date:9/22/2017)... ... ... “Cursed with a Curse: The Truth about Tithing”: a ... when breaking free from this misconception. “Cursed with a Curse: The Truth about ... Christian Faith Publishing, Lysa M. Harrison’s new book is a powerful and thought-provoking ...
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg freezing and embryo ... embryos have a slight statistical advantage for live births, frozen eggs offer many ... for women undergoing medical treatment or who are concerned about the decline of ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , ... wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 7, 2017  Eli Lilly and Company (NYSE: ... streamline operations to more efficiently focus resources on ... structure. Global workforce reductions, including those from a ... impact approximately 3,500 positions. With ... savings of approximately $500 million that will begin ...
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... ORANGEBURG, N.Y. , Sept. 6, 2017   PDI ... today announced it will host an educational session focused ... line-associated bloodstream infection (CLABSI) prevention at the 2017 Annual ... meeting, which will take place at the ... Arizona from Sept. 16-19, will also feature ...
Breaking Medicine Technology:
Cached News: